Nicole LaBrosse
Directeur Financier/CFO chez HALOZYME THERAPEUTICS, INC.
Fortune : 810 533 $ au 30/06/2024
Postes actifs de Nicole LaBrosse
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur Financier/CFO | 02/02/2022 | - |
| Comptroller/Controller/Auditor | 01/01/2017 | 02/02/2022 | |
| Directeur/Membre du Conseil | 01/01/2017 | 01/01/2020 | |
| ANTARES PHARMA, INC. | Directeur/Membre du Conseil | 24/05/2022 | - |
Historique de carrière de Nicole LaBrosse
Anciens postes connus de Nicole LaBrosse
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01/01/2004 | 01/01/2015 |
Formation de Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Nouvelle-Zélande | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Bourse
- Insiders
- Nicole LaBrosse
- Expérience
